Building Research Capacity in Global Tobacco Product Regulation Program

全球烟草产品监管计划研究能力建设

• 批准号: 10764876
• 负责人: Vinayak Prasad
• 金额: $ 40万
• 依托单位: WORLD HEALTH ORGANIZATION
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-08-01 至 2028-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10764876
• 关键词: Building; Research; Capacity; Global; Tobacco

Abstract Building Research Capacity in Global Tobacco Product Regulation Program (U18) Tobacco kills over 8 million people globally every year and eventually kills half of its users, the majority of whom are recruited as children. 480,000 of those deaths are attributable to cigarette smoking in the United States, including more than 41,000 deaths resulting from second-hand smoke exposure. The devastating effects of tobacco products also affects generations due to the debilitating diseases associated with tobacco use including cancer, heart, and respiratory illnesses. Further, the negative consequences of tobacco use are compounded by the strategies employed by tobacco and related manufacturers, who carefully engineer their products to sustain use. In recent times, the introduction of electronic cigarettes to many markets globally has further complicated tobacco control. The paucity of reliable data on these products to support policy making is also a challenge. Therefore, regulating the manufacture, labelling, sale, distribution, advertising and promotion of nicotine and tobacco products has proven particularly challenging in many contexts, even for countries that have strong regulatory measures in place to address these products, such as the United States with the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act), (P.L. 111-31). Through this project, WHO will use its unique history, position, networks and contacts in international tobacco control and tobacco product regulation to support the Food and Drug Administration (the FDA) in reducing tobacco use, harm, and addiction. WHO's experience in this area, includes managing the WHO Study Group on Tobacco Product Regulation, the WHO Tobacco Laboratory Network, its Collaborating Centres, and the Global Tobacco Regulators Forum (GTRF). Further, its track record of managing and coordinating the “Building Research Capacity in Global Tobacco Product Regulation Program” since 2015, will ensure that the requirements of the program are met. Building on lessons learned and WHO's extensive networks, this proposal sets out several science-based activities over the next five years to advance and strengthen research to support tobacco product regulation. These include development and coordination of multilateral research efforts in science, law, policy, and public health communications. The project will also expand data collection and information sharing mechanisms, management and reporting protocol. Carefully designed reporting mechanisms will ensure that WHO monitors, evaluates program activities, tracks progress, and timely disseminates outcomes. As the FDA's Center for Tobacco Products (CTP) continues to exercise its mandate to place restrictions on the sale and distribution of tobacco products, implement tobacco product standards, review applications for new tobacco products, and consider applications for modified risk products, the information from this project, including from countries, will enable the US to consider global regulatory and marketing trends on nicotine and tobacco products. Further, the project will advance global knowledge on product regulation thereby supporting effective regulation of nicotine and tobacco products in WHO Member States.

抽象的 全球烟草产品监管计划研究能力建设（U18） 烟草每年在全球造成超过 800 万人死亡，并最终导致一半使用者死亡，其中大多数是 他们是在儿童时期被招募的。在美国，其中 48 万人死于吸烟 各州有超过 41,000 人因接触二手烟而死亡。毁灭性的影响 由于与烟草使用相关的衰弱疾病，烟草制品的危害也影响了几代人 包括癌症、心脏病和呼吸系统疾病。此外，吸烟的负面后果是 烟草及相关制造商所采用的策略使情况更加复杂，他们精心设计了自己的产品 维持使用的产品。近年来，电子烟被引入全球许多市场。 烟草控制进一步复杂化。这些产品缺乏支持政策制定的可靠数据 也是一个挑战。因此，规范制造、标签、销售、分销、广告和促销 事实证明，尼古丁和烟草制品在许多情况下特别具有挑战性，即使对于那些 拥有强有力的监管措施来应对这些产品，例如美国的 Family 《预防吸烟和烟草控制法》（《烟草控制法》），（P.L. 111-31）。 通过该项目，世卫组织将利用其在国际烟草领域的独特历史、地位、网络和联系 控制和烟草产品监管，以支持美国食品和药物管理局 (FDA) 减少 烟草的使用、危害和成瘾。世卫组织在这一领域的经验，包括管理世卫组织研究组 烟草产品监管、世界卫生组织烟草实验室网络、其合作中心以及 全球烟草监管机构论坛（GTRF）。此外，其管理和协调的记录 自 2015 年起的“全球烟草产品监管研究能力建设计划”将确保 满足该计划的要求。该提案以吸取的经验教训和世卫组织的广泛网络为基础 制定了未来五年内的几项基于科学的活动，以推进和加强研究以支持 烟草产品监管。其中包括发展和协调多边研究工作 科学、法律、政策和公共卫生传播。该项目还将扩大数据收集和 信息共享机制、管理和报告协议。精心设计的报告 机制将确保世卫组织监测、评估规划活动、跟踪进展情况并及时 传播成果。随着 FDA 烟草制品中心 (CTP) 继续履行其职责， 限制烟草产品的销售和分销，实施烟草产品标准，审查 新型烟草产品的申请，并考虑改良风险产品的申请，信息 该项目（包括各国）将使美国能够考虑全球监管和营销 尼古丁和烟草制品的趋势。此外，该项目将推进全球产品知识 从而支持世卫组织成员国对尼古丁和烟草产品的有效监管。